Sana Biotechnology SANA Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Sana Biotechnology’s reported figures.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's free cash flow?
- Sana Biotechnology (SANA) reported free cash flow of -$37.67M in Q1 2026.
- How has Sana Biotechnology's free cash flow changed year-over-year?
- Sana Biotechnology's free cash flow increased by 22.8% year-over-year, from -$48.79M to -$37.67M.
- What is the long-term trend for Sana Biotechnology's free cash flow?
- Over 4 years (2021 to 2025), Sana Biotechnology's free cash flow has grown at a -15.3% compound annual growth rate (CAGR), from -$280.92M to -$144.77M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.